HIV Prevention and Care Engagement in Nepal
Sweekar - Multi-level Intersectional Stigma Reduction Intervention to Increase HIV Testing and Care Engagement in Nepal
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kathmandu, Nepal
- BDS
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- aged 18 years old or older
- identify as transgender, hijra, Meti, third gender or anything other than a gender typically associated with a male assigned sex at birth
- live in the Terai highway district Madesh Province
- Maithili- or Nepali-speaking
- Willing to be part of the study for 6 months
- Willing to travel, if needed, to participate in group sessions
For those who test HIV negative:
- Willing to self-test
- Have or willing to have a mobile phone
- Not HIV tested within the last 3 months
For those who test HIV positive:
(a) screen positive for HIV treatment non-adherence by self-report
Exclusion Criteria:
- Cannot or will not consent to the research,
- Female sex assigned at birth,
- Self-identify as a man
- Do not speak Maithli or Nepali
- Age under 18 -
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group-based intervention
Group-based activities and HIV self-testing to address social stigma and HIV prevention and care needs
|
The HIV prevention components focus on HIV education and use of HIV self-testing kits to increase frequency of HIV testing.
The HIV care component is information and linkage to HIV treatment information and adherence support.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HIV testing Self-testing kits
Time Frame: At baseline and at 3 months
|
Number of HIV self tests kits used at home or at a hospital or clinic
|
At baseline and at 3 months
|
|
HIV testing frequency
Time Frame: Baseline, 3 months and 6 months
|
HIV testing; Number of times received HIV testing using clinic or resources that is not HIV self-testing kits
|
Baseline, 3 months and 6 months
|
|
HIV treatment engagement
Time Frame: At baseline, 3 months and 6 months
|
Self-reported Wilson's Medication Scale to assess adherence patterns.
|
At baseline, 3 months and 6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 4632024
- R01TW012397 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.